Business Finland, the government organization for innovation funding and trade, travel and investment promotion, has published a brochure on ‘Cancer Expertise from Finland’. The digital booklet showcases Finland as a global leader in cancer research
We are very happy that LS CancerDiag has been selected to be part of the first cohort of the X-Europe programme – HealthTech, MedTech and BioTech! LS CancerDiag is proud to have been selected from the
We are delighted to announce that LS CancerDiag has been selected as a participant to the EIT Health Bridghead Global programme! The Bridgehead programme provides European start-ups and scale-ups with individualised support in growing their
Back in January when we were living in a different world, our CBO Philippe Arnez talked with Logan Plaster at the StartUp Health Festival in San Francisco. You can watch the full interview below which
Lynch syndrome. Even though it is the most common hereditary cancer syndrome in the world, it is mostly unknown. Lynch syndrome prevalence is currently estimated at 1 in 279 globally[1], meaning that in Europe alone
We are living through truly unprecedented times. As a company we are taking all the necessary precautions to keep our employees safe, while continuing to serve our customers. However, we also want to take a
LS CancerDiag gets the patent granted in Brazil for its innovative DiagMMR® test. The largest country in Latin America completes the already impressive patent portfolio of LS CancerDiag. Brazil brings the total count to 29
Back in January, our CBO Philippe Arnez spent two days at the Startup Health Festival in San Francisco. LS CancerDiag is proud to be part of this dynamic and inspiring community. We are glad to
LS CancerDiag looks back on the year marked by the achievement of major milestones. 2019 started off with obtaining the CE mark for DiagMMR® as in vitro diagnostic medical device (IVD MD), enabling commercialization in
The last year of this decade has been a very successful one for LS CancerDiag, where many important milestones were achieved, and the basis was laid for strong growth over the coming years. To gear
For those attending @CGAIGC conference make sure to check out the virtual poster from our brilliant CSO Minttu Kansikas (et al): '#DiagMMR, a novel carrier test to detect inherited MMR deficiency' in the event app (under #LynchSyndrome) #CGAIGC20 #MissionCancer
The US celebrated #GCAwarenessDay yesterday honoring the #GeneticCounselor profession. Europe must increase its #GeneticCounseling capacity and implement corresponding curricula. If genetics is going to transform healthcare, suitable education is critical. https://bit.ly/3krR9oa
Excellent work by @frankbalaguer showing how the quality of colonoscopies impacts early detection and therefore #CancerPrevention in LS patients. More evidence for the importance of #LynchSyndrome awareness and finding families at risk! #MissionCancer #DiagMMR
Quality of colonoscopy is associated with adenoma detection and post-colonoscopy colorectal cancer prevention in #Lynchsyndrome - congrats @frankbalaguer for this hugely important study https://pubmed.ncbi.nlm.nih.gov/33157315/
Thanks @startuphealth for the shout out, we're happy to have Philippe present @lscancerdiag and #DiagMMR at @FrontiersHealth this week! #FH20 #MissionCancer #LynchSyndrome
Join Philippe Arnez, Chief Business Officer at StartUp Health co @lscancerdiag, at the @FrontiersHealth Global Conference Friday, Nov 13, where he'll be presenting in the Start-up Discovery Sessions - Personal genetics & genomics segment. Register ⬇️
http://ow.ly/c5GI50CgzHl
